2024 Partners
Johnson Matthey
Exhibition Partner
At Johnson Matthey, we work globally with our pharmaceutical customers to deliver complex chemistry solutions for a healthier world. Our proven expertise, together with our biocatalysis portfolio, capabilities, and screening to scale up services, helps to accelerate your development and optimize processes to make your chemistry more selective, efficient, and sustainable.
Imperagen
Event Partner
Imperagen is a rapidly growing, UK based TechBio company on a mission to transform enzyme innovation. Our Digital Enzyme Evolution™ platform combines laboratory robotics with AI-directed enzyme design in a streamlined architecture. The integrated workflow seamlessly designs, builds, and screens targeted enzyme libraries, gathering high quality data through automated cycles. Our goal is to deliver faster, more substantial performance gains in fewer iterations, producing enzymes engineered precisely for their end application, and more rapidly bridging the gap from concept to market-ready.
Codexis
Event Partner
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
Ginkgo
Event Partner
Accelerate your R&D with Ginkgo's Platform and Experts!
Ginkgo's integrated platform offers solutions for every phase of pre-clinical R&D. Whether you're an early stage company or global enterprise, we customize our approach to your needs. Our collaborative model combines your expertise with ours to accelerate your therapeutic development. Our proprietary enzyme sequence database, combined with AI, unlock vast possibilities for optimizing biocatalysts for your specific needs. We screen and engineer in industry-leading expression hosts, including proprietary high-production strains of methanol-free Pichia pastoris. We support your full development journey—from novel enzyme discovery through production optimization and tech transfer to cGMP manufacturing.
Exazyme
Innovation Partner
Exazyme empowers innovators in pharmaceuticals, industrial, and green biotechnology to tackle global challenges, from CO2 reduction to cancer research. We use advanced AI to
revolutionize protein design, significantly reducing the number of required experiments and accelerating breakthroughs. Whether optimizing existing measurements or designing new enzyme variants, our machine learning models provide tailored suggestions. By efficiently exploring the protein space and learning from both successful and non-performing variants, Exazyme delivers faster, more precise results.
Scala Biodesign
Innovation Partner
Scala Biodesign develops one-shot enzyme design software that accelerates the development of high-efficiency, high-yield enzymes with minimal experimental time and effort. Scala’s technologies have been validated by over 50 research labs and top pharma companies, demonstrating versatility across enzyme families and applications. Scala’s platform enables biocatalysis teams to rapidly optimize enzyme stability, selectivity, and activity independently by incorporating multiple mutations in a small number of variants through a single design round
Biocatalysts Ltd
Innovation Partner
BRAIN-Biocatalysts Life Science Solutions, the result of a powerful combination of BRAIN Biotech AG’s expertise in enzyme discovery and optimisation with Biocatalysts Ltd’s commercial-scale manufacturing capabilities. Offering end-to-end enzyme solutions - from discovery and development to large-scale production - designed to meet the evolving needs of the life sciences industry. We simplify biocatalysis, delivering tailored, scalable solutions ensuring your product, your IP, and your future are fully supported.
Twist Bioscience
Innovation Partner
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research
Kaneka
Expertise Partner
Kaneka is a technology-driven company providing valuable CDMO services to our global partners for nearly 50 years. As a pioneer in enzyme technology, we have been producing an array of chiral compounds using Biocatalysis. Here, we present some examples of enzymatic process development and scale-up for chiral compounds which are key intermediates for our customer’s pharmaceutical development and commercial programs. Kaneka offers seamless and robust customer support, from enzymatic route design to to scale production.